With four diagnostic FDA shots on goal scheduled over weeks and months ahead, any single approval will equal hundreds of millions of dollars in annual opportunity. Getting all four approved will provide an annual revenue opportunity in the Billions. High margin opportunities like these afford very rich evaluation models.
While the $400K man that resided in Michigan and spent the last 9 months getting to know SQI is no longer a part of the go forward strategy, the key Directors that have determined SQI's flight path remain firmly in the pilot's seat. SQI's Science, Quality and Innovation has been in the making for over two decades and is set for exploitation.
Most importantly, SQI remains largely in STEALTH mode, an untold/unshared story that has yet to be valued based on an informed market of integrity. This elusive yet simple task remains the responsibility of the B of D's, and is well past due. It's all about win-win scenarios for all from here....
With great/innovative technology comes great responsibilities. Lives matter. Its time for pride....